Significant to this issue, Julieta E. Laiseca’s group has reported that MAGE-A11 and MAGE-A6 form a protein complex leading to the MAGE-A11 stabilization and consequently the AR activity augmentation and promote tumor progression in prostate cancer27. Here, MAGEA6 is linked to neoplasm.